Skip to main content
Clinical Trials/NCT07559448
NCT07559448
Not yet recruiting
Not Applicable

Feasibility of a Novel Oral Palatable Elemental Diet for Gastrointestinal Symptoms in Chronic Pancreatitis

Stanford University1 site in 1 country15 target enrollmentStarted: July 1, 2026Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
15
Locations
1
Primary Endpoint
Number of Participants Who Complete at Least 12 of 14 Days of the Palatable Elemental Diet

Overview

Brief Summary

The goal of this clinical trial is to learn whether a 2-week exclusive palatable elemental diet is feasible, tolerable, and acceptable for adults with chronic pancreatitis and bothersome gastrointestinal symptoms. The main questions it aims to answer are whether participants can complete the diet as planned and whether they can take in most of the prescribed formula.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adults aged 18 to 75 years
  • Clinical diagnosis of chronic pancreatitis based on medical history and study physician assessment
  • Self-reported chronic pancreatitis-related gastrointestinal symptoms within 30 days before enrollment, with significant global gastrointestinal symptom burden defined as a Structured Assessment of Gastrointestinal Symptoms (SAGIS) score of 16 or higher

Exclusion Criteria

  • Pancreatic tumor or pancreatic cancer
  • History of pancreatic surgery
  • Pregnancy or breastfeeding
  • Diagnosis of a condition other than chronic pancreatitis that contributes to gastrointestinal symptoms, based on medical history or study physician assessment
  • Active infection or antibiotic use within the last month
  • History of phenylketonuria
  • Insulin-dependent diabetes or diabetes requiring insulin treatment

Arms & Interventions

Palatable Elemental Diet

Experimental

Participants in this single-arm study will consume an exclusive oral palatable elemental diet for 14 days. During the intervention period, participants will complete daily diet and symptom diaries and undergo study assessments, including questionnaires and biospecimen collection. After the 14-day diet period, participants will resume their usual diet and continue follow-up for 4 additional weeks.

Intervention: Palatable Elemental Diet (Other)

Outcomes

Primary Outcomes

Number of Participants Who Complete at Least 12 of 14 Days of the Palatable Elemental Diet

Time Frame: During the 14-day exclusive palatable elemental diet period (Day 14 to Day 28)

Completion is defined as completing at least 12 of the 14 study diet days during the exclusive palatable elemental diet period. The feasibility target is that at least 80% of participants meet this criterion.

Number of Participants Who Consume at Least 75% of Prescribed Palatable Elemental Diet Calories

Time Frame: During the 14-day exclusive palatable elemental diet period (Day 14 to Day 28)

Diet adherence is defined as consuming at least 75% of prescribed palatable elemental diet calories during the 14-day exclusive diet period, based on daily diary tracking. The feasibility target is that at least 75% of participants meet this criterion.

Secondary Outcomes

  • Change From Baseline in SAGIS Global Symptom Burden Score(Baseline, Day 28 (end of PED), and Day 56)
  • Change From Baseline in PROMIS Global Health v1.2 Summary Score(Baseline, Day 28 (end of PED), and Day 56)
  • Change From Baseline in Selected PROMIS-29 v2.0 Domain Scores(Baseline, Day 28 (end of PED), and Day 56)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Yi Jiang

Assistant Clinical Professor

Stanford University

Study Sites (1)

Loading locations...

Similar Trials